ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 270 filers reported holding ALKERMES PLC in Q2 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $6,944,000 | +0.8% | 107,928 | -4.5% | 0.01% | 0.0% |
Q1 2015 | $6,888,000 | +25.6% | 112,973 | +20.7% | 0.01% | +20.0% |
Q4 2014 | $5,482,000 | +108.0% | 93,613 | +52.3% | 0.01% | +66.7% |
Q3 2014 | $2,635,000 | -4.1% | 61,469 | +12.6% | 0.00% | 0.0% |
Q2 2014 | $2,748,000 | +73.2% | 54,604 | +51.8% | 0.00% | +50.0% |
Q1 2014 | $1,587,000 | -18.4% | 35,979 | -24.8% | 0.00% | -33.3% |
Q4 2013 | $1,946,000 | +9.5% | 47,860 | -9.5% | 0.00% | 0.0% |
Q3 2013 | $1,777,000 | -18.9% | 52,858 | -30.8% | 0.00% | 0.0% |
Q2 2013 | $2,192,000 | – | 76,439 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
13D Management LLC | 415,055 | $9,268,000 | 4.85% |
Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |